Skip to main content
Top
Published in: Neuroradiology 2/2024

21-12-2023 | Oligodendroglioma | Diagnostic Neuroradiology

The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods

Authors: Koji Yamashita, Osamu Togao, Kazufumi Kikuchi, Daisuke Kuga, Yuhei Sangatsuda, Yutaka Fujioka, Koji Yoshimoto, Kousei Ishigami

Published in: Neuroradiology | Issue 2/2024

Login to get access

Abstract

Purpose

The cortical high-flow sign with the non-enhancing area was reportedly found to be more frequent with oligodendroglioma, IDH-mutant and 1p/19q codeleted (ODG IDHm-codel) than with IDH-wildtype or astrocytoma, IDH-mutant on arterial spin labeling (ASL) in diffuse gliomas. This study aimed to compare the identification rate of the cortical high-flow sign on ASL in patients with ODG IDHm-codel to that on dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI).

Methods

Participants consisted of 32 adult ODG IDHm-codel patients with pathologically confirmed. Subtraction images were generated from paired control and label images on ASL. For DSC, dynamic T2*-weighted perfusion weighted images were obtained after pre-bolus of gadolinium-based contrast agent. Regional cerebral blood flow/volume maps were generated based on the concentration–time curve and arterial input function. Tumor-affecting cortices without contrast enhancement on conventional MR imaging were targeted. The identification rate of the cortical high-flow sign was compared between ASL and DSC using the Pearson’s Chi-Square test.

Results

Frequency of the cortical high-flow sign was significantly higher on ASL (18/32, 56.3%; p < 0.001) than on DSC (5/32, 15.6%). All cases with the positive cortical high-flow sign on DSC were identified on ASL.

Conclusion

ASL effectively identifies the cortical high-flow sign in ODG IDHm-codel, surpassing DSC in identification rates.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yamashita K, Togao O, Kikuchi K et al (2023) Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement. Neuroradiology 65:1415–1418CrossRefPubMed Yamashita K, Togao O, Kikuchi K et al (2023) Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement. Neuroradiology 65:1415–1418CrossRefPubMed
2.
go back to reference WHO Classification of Tumours Editorial Board (2021) World Health Organization classification of tumours of the central nervous system, 5th edn. International Agency for Research on Cancer, Lyon WHO Classification of Tumours Editorial Board (2021) World Health Organization classification of tumours of the central nervous system, 5th edn. International Agency for Research on Cancer, Lyon
3.
go back to reference Van den Bent MJ, Reni M, Gatta G, Vecht C (2008) Oligodendroglioma. Crit Rev Oncol Hematol 66:262–272CrossRefPubMed Van den Bent MJ, Reni M, Gatta G, Vecht C (2008) Oligodendroglioma. Crit Rev Oncol Hematol 66:262–272CrossRefPubMed
4.
go back to reference Weber MA, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906CrossRefPubMed Weber MA, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906CrossRefPubMed
5.
go back to reference Noguchi T, Yoshiura T, Hiwatashi A et al (2008) Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 29:688–693CrossRefPubMedPubMedCentral Noguchi T, Yoshiura T, Hiwatashi A et al (2008) Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 29:688–693CrossRefPubMedPubMedCentral
6.
go back to reference Yamashita K, Hiwatashi A, Togao O et al (2016) MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status. AJNR Am J Neuroradiol 37:58–65CrossRefPubMedPubMedCentral Yamashita K, Hiwatashi A, Togao O et al (2016) MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status. AJNR Am J Neuroradiol 37:58–65CrossRefPubMedPubMedCentral
7.
go back to reference Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMedPubMedCentral Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMedPubMedCentral
8.
go back to reference Boxerman JL, Quarles CC, Hu LS et al (2020) Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol 22:1262–1275CrossRefPubMedPubMedCentral Boxerman JL, Quarles CC, Hu LS et al (2020) Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol 22:1262–1275CrossRefPubMedPubMedCentral
9.
go back to reference Järnum H, Steffensen EG, Knutsson L et al (2009) Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 52:307–317CrossRefPubMedPubMedCentral Järnum H, Steffensen EG, Knutsson L et al (2009) Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 52:307–317CrossRefPubMedPubMedCentral
10.
go back to reference Xu Q, Liu Q, Ge H et al (2017) Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Medicine (Baltimore) 96:e9332CrossRefPubMed Xu Q, Liu Q, Ge H et al (2017) Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Medicine (Baltimore) 96:e9332CrossRefPubMed
11.
go back to reference Lavrova A, Teunissen WHT, Warnert EAH, van den Bent M, Smits M (2022) Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI. Front Oncol 12:849657CrossRefPubMedPubMedCentral Lavrova A, Teunissen WHT, Warnert EAH, van den Bent M, Smits M (2022) Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI. Front Oncol 12:849657CrossRefPubMedPubMedCentral
12.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
13.
go back to reference Koeller KK, Rushing EJ (2005) From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation. Radiographics 25:1669–1688CrossRefPubMed Koeller KK, Rushing EJ (2005) From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation. Radiographics 25:1669–1688CrossRefPubMed
15.
go back to reference Latysheva A, Emblem KE, Brandal P et al (2019) Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach. Neuroradiology 61:545–555CrossRefPubMed Latysheva A, Emblem KE, Brandal P et al (2019) Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach. Neuroradiology 61:545–555CrossRefPubMed
16.
go back to reference Qi Y, Roper M (2021) Control of low flow regions in the cortical vasculature determines optimal arterio-venous ratios. Proc Natl Acad Sci U S A 118:e2021840118 Qi Y, Roper M (2021) Control of low flow regions in the cortical vasculature determines optimal arterio-venous ratios. Proc Natl Acad Sci U S A 118:e2021840118
17.
go back to reference Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–235CrossRefPubMed Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–235CrossRefPubMed
18.
go back to reference Smits A, Duffau H (2011) Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery 68:1326–1333CrossRefPubMed Smits A, Duffau H (2011) Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery 68:1326–1333CrossRefPubMed
19.
go back to reference Kerkhof M, Benit C, Duran-Pena A, Vecht CJ (2015) Seizures in oligodendroglial tumors. CNS. Oncol 4:347–356 Kerkhof M, Benit C, Duran-Pena A, Vecht CJ (2015) Seizures in oligodendroglial tumors. CNS. Oncol 4:347–356
20.
go back to reference Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402CrossRefPubMed Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402CrossRefPubMed
Metadata
Title
The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods
Authors
Koji Yamashita
Osamu Togao
Kazufumi Kikuchi
Daisuke Kuga
Yuhei Sangatsuda
Yutaka Fujioka
Koji Yoshimoto
Kousei Ishigami
Publication date
21-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Neuroradiology / Issue 2/2024
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-023-03267-x

Other articles of this Issue 2/2024

Neuroradiology 2/2024 Go to the issue